Evidence map›Paper›PMID 30669455›Full record

ArticleCancers2019

Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway.

Ewelina Majewska, Javier Márquez, Jan Albrecht, Monika Szeliga

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Cancers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.0field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 23 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Ewelina MajewskaDepartment of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego Street, 02-106 Warsaw, Poland. emajewska@imdik.pan.pl.
Javier MárquezCanceromics Laboratory, Department of Molecular Biology and Biochemistry, Faculty of Sciences, Campus de Teatinos, Instituto de Investigación Biomédica de Málaga (IBIMA), University of Málaga, 29071 Málaga, Spain. marquez@uma.es.ORCID 0000-0003-3317-3963
Jan AlbrechtDepartment of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego Street, 02-106 Warsaw, Poland. jalbrecht@imdik.pan.pl.ORCID 0000-0001-6063-6228
Monika SzeligaDepartment of Neurotoxicology, Mossakowski Medical Research Centre, Polish Academy of Sciences, 5 Pawińskiego Street, 02-106 Warsaw, Poland. mszeliga@imdik.pan.pl.ORCID 0000-0003-2973-4692
Mossakowski Medical Research Institute, Polish Academy of Sciences · PLInstituto de Investigación Biomédica de Málaga · ES

Funding

National Leading Research Centre KNOW-MMRC1 (to E.M.)National Science Centre of Poland 2013/11/D/NZ7/00925 (to M.S.)National Science Centre of Poland 2016/23/N/NZ5/01428 (to E.M.)National Science Centre of Poland 2017/25/B/NZ7/00388 (to M.S.)Spanish Ministry of Economy and Competitivity SAF2015-64501-R (to J.M.)
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

GLS2 glutaminasehuman glioblastomaoxidative stressPI3K/AKT signaling pathway

Identifiers

PMID30669455
PMCPMC6356507
OpenAlexW2910854109

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.